Related Experiment Video
Updated: Jan 27, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Mechanistic target of rapamycin signaling in mouse models of accelerated aging
Jin Young Lee1, Brian K Kennedy1,2,3,4, Chen-Yu Liao1
1Buck Institute for Research on Aging, Novato, California.
Abstract:
The mechanistic target of rapamycin (mTOR) is an essential nutrient-sensing kinase that integrates and regulates a number of fundamental cellular processes required for cell growth, cell motility, translation, metabolism, and autophagy. mTOR signaling has been implicated in the progression of many human diseases, and its dysregulation has been reported in several pathological processes, especially in age-related human diseases and mouse models of accelerated aging. In addition, many studies have demonstrated that the regulation of mTOR activity has a beneficial effect on longevity in several mouse models of aging. However, not all mouse models of accelerated aging show positive effects on aging-associated phenotypes in response to targeting mTOR signaling. Here, we review the effects of interventions that modulate mTOR signaling on aging-related phenotypes in different mouse models of accelerated aging and discuss their implications with respect to aging and aging-related disorders.
Insights
Targeting mechanistic target of rapamycin (mTOR) signaling shows varied effects on aging in mouse models. This review examines how modulating mTOR impacts aging phenotypes and related disorders.
Area of Science:
- Cellular Biology
- Biochemistry
- Gerontology
Background:
- Mechanistic target of rapamycin (mTOR) is a key nutrient-sensing kinase regulating vital cellular functions like growth, metabolism, and autophagy.
- Dysregulated mTOR signaling is linked to human diseases, particularly age-related conditions and accelerated aging in mouse models.
Purpose of the Study:
- To review the impact of mTOR signaling modulation on aging phenotypes across diverse accelerated aging mouse models.
- To discuss the implications of these findings for understanding aging and age-related disorders.
Main Methods:
- Literature review of studies investigating mTOR signaling interventions in mouse models of accelerated aging.
- Analysis of reported effects on aging-associated phenotypes.
Main Results:
- While some studies show beneficial effects of mTOR targeting on longevity and aging phenotypes in mice.
- Not all accelerated aging mouse models exhibit positive responses to mTOR pathway modulation.
Conclusions:
- The effect of targeting mTOR signaling on aging is complex and model-dependent.
- Further research is needed to clarify mTOR's role in aging and its therapeutic potential for age-related diseases.
Related Concept Videos
Mechanistic Models: Overview of Compartment Models
Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Accelerators
The effectiveness of calcium chloride can...
Small-signal Diode Model
Accelerating Fluids
The motion of the liquid within this infinitesimal cylinder is considered to obtain the pressure difference. Three vertical forces act on this liquid:

